Testing effectiveness (Phase 2)Study completedNCT04056195
What this trial is testing
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)
Who this might be right for
Immune Thrombocytopenia
Oscotec Inc. 61